ES8606295A1 - Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas. - Google Patents
Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas.Info
- Publication number
- ES8606295A1 ES8606295A1 ES541450A ES541450A ES8606295A1 ES 8606295 A1 ES8606295 A1 ES 8606295A1 ES 541450 A ES541450 A ES 541450A ES 541450 A ES541450 A ES 541450A ES 8606295 A1 ES8606295 A1 ES 8606295A1
- Authority
- ES
- Spain
- Prior art keywords
- heteroazolidindionas
- procedure
- preparation
- new
- spire
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59301284A | 1984-03-23 | 1984-03-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES541450A0 ES541450A0 (es) | 1986-04-16 |
| ES8606295A1 true ES8606295A1 (es) | 1986-04-16 |
Family
ID=24372993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES541450A Expired ES8606295A1 (es) | 1984-03-23 | 1985-03-21 | Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0159143B1 (en]) |
| JP (1) | JPS60209572A (en]) |
| KR (1) | KR850006188A (en]) |
| AU (1) | AU563668B2 (en]) |
| CA (1) | CA1244443A (en]) |
| DE (1) | DE3561198D1 (en]) |
| DK (1) | DK131885A (en]) |
| ES (1) | ES8606295A1 (en]) |
| FI (1) | FI851170L (en]) |
| GR (1) | GR850704B (en]) |
| HU (1) | HU195783B (en]) |
| IL (1) | IL74667A (en]) |
| PH (1) | PH23921A (en]) |
| PL (1) | PL145198B1 (en]) |
| PT (1) | PT80145B (en]) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
| GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| WO2004082678A1 (en) * | 2003-03-14 | 2004-09-30 | Merck & Co. Inc. | Aryl spirohydantoin cgrp receptor antagonists |
| JP2008512489A (ja) * | 2004-09-13 | 2008-04-24 | メルク エンド カムパニー インコーポレーテッド | 三環式アニリドスピロヒダントインｃｇｒｐ受容体拮抗薬 |
| DE602006019304D1 (de) | 2005-11-18 | 2011-02-10 | Merck Sharp & Dohme | Spirohydantoin-aryl-cgrp-rezeptorantagonisten |
| CN111732545B (zh) * | 2020-06-08 | 2023-03-10 | 华侨大学 | 一种2,3-二氢螺[咪唑-4,1′-茚]类化合物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4117230A (en) * | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
| US4226875A (en) * | 1979-04-02 | 1980-10-07 | Pfizer Inc. | Novel spiro-oxazolidinediones |
| ES8400116A1 (es) * | 1981-10-13 | 1983-10-16 | Pfizer | "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona". |
| ZA832679B (en) * | 1982-05-07 | 1983-12-28 | Ici Plc | Indoline derivatives |
| US4556670A (en) * | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
-
1985
- 1985-03-15 EP EP85301809A patent/EP0159143B1/en not_active Expired
- 1985-03-15 DE DE8585301809T patent/DE3561198D1/de not_active Expired
- 1985-03-19 PH PH32003A patent/PH23921A/en unknown
- 1985-03-20 GR GR850704A patent/GR850704B/el unknown
- 1985-03-20 IL IL74667A patent/IL74667A/xx unknown
- 1985-03-21 KR KR1019850001848A patent/KR850006188A/ko not_active Ceased
- 1985-03-21 PT PT80145A patent/PT80145B/pt unknown
- 1985-03-21 ES ES541450A patent/ES8606295A1/es not_active Expired
- 1985-03-21 CA CA000477079A patent/CA1244443A/en not_active Expired
- 1985-03-21 PL PL1985252487A patent/PL145198B1/pl unknown
- 1985-03-22 HU HU851108A patent/HU195783B/hu not_active IP Right Cessation
- 1985-03-22 DK DK131885A patent/DK131885A/da not_active Application Discontinuation
- 1985-03-22 JP JP60057640A patent/JPS60209572A/ja active Pending
- 1985-03-22 AU AU40251/85A patent/AU563668B2/en not_active Ceased
- 1985-03-22 FI FI851170A patent/FI851170L/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK131885D0 (da) | 1985-03-22 |
| PT80145A (en) | 1985-04-01 |
| CA1244443A (en) | 1988-11-08 |
| HU195783B (en) | 1988-07-28 |
| ES541450A0 (es) | 1986-04-16 |
| JPS60209572A (ja) | 1985-10-22 |
| PT80145B (en) | 1987-03-23 |
| PL252487A1 (en) | 1985-10-08 |
| IL74667A (en) | 1988-12-30 |
| FI851170A7 (fi) | 1985-09-24 |
| IL74667A0 (en) | 1985-06-30 |
| AU4025185A (en) | 1985-09-26 |
| KR850006188A (ko) | 1985-10-02 |
| DK131885A (da) | 1985-09-24 |
| PL145198B1 (en) | 1988-08-31 |
| AU563668B2 (en) | 1987-07-16 |
| HUT37603A (en) | 1986-01-23 |
| DE3561198D1 (en) | 1988-01-28 |
| FI851170L (fi) | 1985-09-24 |
| FI851170A0 (fi) | 1985-03-22 |
| EP0159143B1 (en) | 1987-12-16 |
| GR850704B (en]) | 1985-07-19 |
| EP0159143A1 (en) | 1985-10-23 |
| PH23921A (en) | 1990-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU22305A3 (es) | Procedimiento para la preparacion de un derivado de aminoacidos | |
| KR830006174A (ko) | 기관지 항경련성 화합물 제조방법 | |
| BR0312464A (pt) | Inibidores de tirosina quinases | |
| KR870006016A (ko) | N-벤조일 우레아 화합물, 이를 함유하는 항종양 조성물 및 그의 제조 방법 | |
| MX9307779A (es) | Compuestos benzoicos fundidos. | |
| ES8606336A1 (es) | Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos | |
| PT674634E (pt) | Processos para preparar 1,3-oxatiolanos substituidos com propriedades antivirais | |
| FR2430939B1 (en]) | ||
| ES2037753T3 (es) | Compuestos heterociclicos y su preparacion y uso. | |
| KR910000730A (ko) | N-헤테로아릴-푸린-6-아민, 이의 제조방법 및 약제로서의 이의 용도 | |
| KR920006327A (ko) | 벤즈이미다졸 유도체, 이의 제조방법 및 용도 | |
| ES8606295A1 (es) | Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas. | |
| PT80820B (pt) | Processo para a preparacao de derivados de 1,3-propilidenodifosfonato 2-substituidos | |
| ATE165827T1 (de) | Herstellung von n-acetylneuraminsäure-derivaten | |
| ES2053856T3 (es) | Derivados del acido 4-quinoleino carboxilico utiles para el tratamiento de enfermedades de la piel y del muco-epitelio. | |
| JPS5649361A (en) | Carbostyril derivative | |
| ES2001703A6 (es) | Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos. | |
| ATE129501T1 (de) | Griseolsäurederivate, ihre herstellung und ihre verwendung. | |
| ES2053668T3 (es) | Derivados de poliamina como agentes antineoplasicos. | |
| PT84564B (pt) | Processo para a preparacao de derivados de acidos dicarboxilicos diazotados substituidos com actividade nootropica | |
| DK102892A (da) | Purin-derivater, farmaceutisk praeparat omfattende forbindelserne samt forbindelser til brug som mellemprodukter | |
| ES8503676A1 (es) | Procedimiento de producir derivados de acido oxazolacetico | |
| ES8800920A1 (es) | Un procedimiento para preparar un derivado de 1,5-benzotiazepina | |
| ES8405391A1 (es) | Un procedimiento para la preparacion de un derivado de tetrahidro-1h-piridoindol. | |
| ATE27813T1 (de) | N-substituierte 1-(4'-alkylsulfonylphenyl)-2amino-1,3-propanediol-derivate. |